DRG1 Antikörper

Produktnummer ABIN7236838

Produktdetails anti-DRG1 Antikörper

Target: DRG1 (Developmentally Regulated GTP Binding Protein 1 (DRG1))

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DRG1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Produktmerkmale: Polyclonal Antibody

Aufreinigung: Affinity purification

Immunogen: Recombinant protein of human DRG1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500-1:2000, IHC 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu DRG1

Target: DRG1 (Developmentally Regulated GTP Binding Protein 1 (DRG1))

Andere Bezeichnung: DRG1 (DRG1 Produkte)

Synonyme: NEDD3 antikoerper, wu:fb06g12 antikoerper, zgc:64124 antikoerper, xdrg antikoerper, xdrg1 antikoerper, MGC122865 antikoerper, AA408859 antikoerper, AI132520 antikoerper, Nedd3 antikoerper, developmentally regulated GTP binding protein 1 antikoerper, developmentally regulated GTP binding protein 1 L homeolog antikoerper, DRG1 antikoerper, Drg1 antikoerper, drg1 antikoerper, drg1.L antikoerper

Hintergrund: DRG1 (developmentally regulated GTP binding protein 1), also known as NEDD3 (neural precursor cell expressed developmentally down-regulated protein 3), is a 367 amino acid protein that localizes to the cytoplasm and belongs to the GTP1/OBG family. Expressed at high levels in heart, kidney and skeletal muscle and at lower levels in brain, liver, placenta, lung, colon and spleen, DRG1 binds to TAL1 and TAL2 and is thought to play a role in cell proliferation and differentiation, as well as in apoptosis, suggesting a role in tumor formation and metastasis. DRG1 is subject to polyubiquitination and sumoylation, the former of which induces proteolytic degradation. The gene encoding DRG1 maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia.

Molekulargewicht: 41 kDa

UniProt: Q9Y295